AGYS CCO sells 607 shares; 419 RSUs convert to stock

Agilysys (AGYS) reported insider transactions by its Chief Commercial Officer.

Rhea-AI Filing Summary

Agilysys (AGYS) reported insider transactions by its Chief Commercial Officer. The filing shows two tax-related sales and one restricted stock unit conversion. On 09/02/2025, 504 shares of Common Stock were sold at $106.88 to cover withholding from an 08/31 vest. On 10/31/2025, 419 RSUs converted to Common Stock at $0 (code M). On 11/03/2025, 103 shares were sold at $124.64 to cover withholding from the 10/31 vest.

Following these transactions, the officer directly owned 20,047 Common Stock shares. Derivative holdings listed include 840 RSUs.

Insider Trade Summary

Exercise and sale activity reported; no spread calculated

Exercise and Sale 4 txns

Insider Abdelrahman Joe Ahmed Youssef

Role Chief Commercial Officer

Sold 607 shs ($67K)

Approx. gross sale proceeds $67K

Approx. exercise cost $0.00

Type	Security	Shares	Price	Value
Sale	Common Stock	103	$124.64	$13K
Exercise	Restricted Stock Units	419	$0.00	$0.00
Exercise	Common Stock	419	$125.46	$53K
Sale	Common Stock	504	$106.88	$54K

Holdings After Transaction: Restricted Stock Units — 840 contracts (Direct); Common Stock — 20,047 shares (Direct)

Footnotes (2)

1. F1. Shares sold to fund withholding tax obligations arising from the vesting of restricted Common Stock on August 31, 2025 (sell to cover).
2. F2. Shares sold to fund withholding tax obligations arising from the vesting of restricted Common Stock on October 31, 2025 (sell to cover).

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider activity did AGYS disclose for the Chief Commercial Officer?

Sales of 504 shares on 09/02/2025 at $106.88, a conversion of 419 RSUs on 10/31/2025, and a sale of 103 shares on 11/03/2025 at $124.64.

Why were the AGYS shares sold by the officer?

The filing states both sales were to fund withholding tax obligations arising from restricted Common Stock vestings (sell to cover).

How many AGYS shares does the officer own after these transactions?

The officer beneficially owned 20,047 shares of Common Stock directly after the reported transactions.

How many RSUs were converted to AGYS Common Stock?

On 10/31/2025, 419 RSUs converted to Common Stock (transaction code M).

What derivative securities remain after the transactions?

The filing lists 840 RSUs beneficially owned following the reported transactions.

What were the transaction codes used in the filing?

Codes include S for sales and M for conversion/exercise related to RSUs.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/04/2025 - 06:20 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Abdelrahman Joe Ahmed Youssef

(Last) (First) (Middle)

3655 BROOKSIDE PARKWAY

SUITE 300

(Street)

ALPHARETTA GA 30022

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AGILYSYS INC [ AGYS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Commercial Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/02/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/02/2025		S(1)		504	D	$106.88	19,731	D
Common Stock	10/31/2025		M		419	A	$125.46	20,150	D
Common Stock	11/03/2025		S(2)		103	D	$124.64	20,047	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	$0	10/31/2025		M			419	10/31/2025	10/31/2025	Common Stock	419	$0	840	D

Explanation of Responses:

1. Shares sold to fund withholding tax obligations arising from the vesting of restricted Common Stock on August 31, 2025 (sell to cover).

2. Shares sold to fund withholding tax obligations arising from the vesting of restricted Common Stock on October 31, 2025 (sell to cover).

	/s/ Kyle C. Badger, Attorney-in-Fact	11/04/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.